Oral antiviral therapy for hepatitis B: the case of besifovir, a new kid on the block with a long way to go. [electronic resource]
- Gut Jun 2014
- 869-70 p. digital
Publication Type: Journal Article; Comment
1468-3288
10.1136/gutjnl-2013-305859 doi
Antibodies, Viral--blood Antiviral Agents--therapeutic use DNA, Viral--blood Female Guanine--analogs & derivatives Hepatitis B virus--immunology Hepatitis B, Chronic--drug therapy Humans Male Organophosphonates--therapeutic use